U.S. market Closed. Opens in 2 days 2 hours 35 minutes

CYTK | Cytokinetics, Incorporated Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
Revenue7.53M94.59M70.43M55.83M26.87M31.50M13.37M106.41M28.66M46.94M30.65M7.56M4.00M2.58M81.54M12.42M13.62M3.13M8.91M13.44M10.58M11.40M8.47MN/A
Cost of Revenue11.89M240.81M159.94M96.95M86.12M89.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-4.36M-146.22M-89.51M-41.12M-59.26M-57.63MN/AN/A28.66M46.94M30.65M7.56M4.00M2.58M81.54M12.42M13.62M3.13M8.91M13.44M10.58M11.40MN/AN/A
Operating Expenses491.84M177.98M96.80M52.82M39.61M31.28M126.76M87.72M66.06M61.69M64.54M48.07M50.77M52.21M55.47M69.03M70.11M64.47M53.55M51.88M43.17M35.38M26.86MN/A
Selling, General & Admin173.61M177.98M96.80M52.82M39.61M31.28M36.47M27.82M19.67M17.27M15.09M12.43M13.59M14.20M15.63M15.08M16.72M15.24M12.97M11.99M9.16M6.95M5.90M3.39M
Research & Development318.23M6.59M159.94M96.95M86.12M89.14M90.30M59.90M46.40M44.43M49.45M35.64M37.18M38.01M39.84M53.95M53.39M49.23M40.57M39.88M34.00M28.42M20.96M10.40M
Other Operating Expenses326.09M-6.59M-159.94M-96.95M-86.12MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-496.20M-324.20M-186.31M-93.94M-98.87M-88.92M-113.40M18.69M-37.41M-14.75M-33.89M-40.51M-46.77M-49.63M26.07M-56.61M-56.49M-61.34M-44.63M-38.43M-32.59M-23.98M-18.39M-13.79M
Other Expenses / Income-30.04M-64.75M-29.00M-33.35M-22.82M-17.37M-14.39M-2.23M-94.00K108.00K177.00K143.00K-1.09M172.00K-1.38M-2.47MN/AN/AN/AN/AN/AN/AN/AN/A
Before Tax Income-526.24M-388.95M-215.31M-127.29M-121.69M-106.29M-127.79M16.45M-37.50M-14.65M-33.72M-40.37M-47.86M-49.46M24.69MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses11.72M13.60M27.06M36.84M27.36M4.19MN/AN/AN/AN/AN/AN/AN/A-176.00K150.00KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-526.24M-402.55M-242.37M-164.13M-149.05M-106.29M-127.79M16.45M-37.50M-14.65M-33.72M-40.37M-47.86M-49.29M24.54M-56.37M-48.89M-57.12M-42.25M-37.20M-32.69M-23.08M-15.87M-13.08M
Interest Expenses57.67M51.16M29.33M38.68M27.36M21.56M17.00M2.70M250.00KN/A79.00K2.00K104.00K163.00K409.00K491.00K699.00K523.00K535.00K549.00K2.49M1.33M438.00K267.00K
Basic Shares Outstanding96.52M89.83M76.89M64.52M57.58M54.42M49.40M39.94M38.81M35.71M27.27M18.11M11.80M10.69M9.57M8.23M7.93M6.10M4.76M3.29M318.50K290.33K236.64K160.87K
Diluted Shares Outstanding96.52M89.83M76.89M64.52M57.58M54.42M49.40M42.56M38.81M35.71M27.27M18.11M11.80M10.69M9.66M8.23M7.93M6.10M4.76M3.29M318.57K290.33K236.64K160.87K
EBITDA-484.31M-312.86M-185.98M-88.61M-93.04M-84.72M-108.87M19.89M-36.66M-14.16M-33.20M-39.78M-46.46M-47.40M27.12M-53.43M-45.37M-53.66M-38.66M-33.37M-27.01M-18.90M-15.44M-13.79M
EBITDA Margin-6,431.78%-330.76%-264.07%-158.73%-346.28%-268.96%-814.44%18.69%-127.93%-30.16%-108.34%-526.22%-1,161.48%-1,839.35%33.27%-430.17%-333.03%-1,716.18%-433.74%-248.27%-255.40%-165.85%-182.33%0.00%
EBIT-456.85M-337.80M-185.98M-88.61M-94.33M-80.53M-110.79M19.15M-37.25M-14.65M-33.64M-40.37M-47.76M-49.30M25.10M-55.88M-48.20M-56.59M-41.72M-36.65M-30.20M-21.75M-15.44M-12.81M
EBIT Margin-6,067.09%-357.13%-264.07%-158.73%-351.09%-255.66%-828.80%18.00%-129.98%-31.20%-109.76%-534.04%-1,193.90%-1,913.08%30.79%-449.94%-353.80%-1,809.79%-468.10%-272.65%-285.48%-190.85%-182.33%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙